share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Officer Weems Alonzo

SEC announcement ·  Feb 14 17:38
Summary by Moomoo AI
Eli Lilly and Co (LLY) executive vice president, risk management, ethics, and compliance officer (EVP, ERM & CECO), Alonzo Weems, completed a stock purchase transaction on February 12, 2024. Weems acquired a total of 951 shares of common stock at a price of $737.26 per share. Following this transaction, Weems directly holds a total of 7,951 shares in the company. The transaction is part of a grant, award, or other acquisition, as per the transaction code description. The total value of the shares acquired by Weems is approximately $701,477.26.
Eli Lilly and Co (LLY) executive vice president, risk management, ethics, and compliance officer (EVP, ERM & CECO), Alonzo Weems, completed a stock purchase transaction on February 12, 2024. Weems acquired a total of 951 shares of common stock at a price of $737.26 per share. Following this transaction, Weems directly holds a total of 7,951 shares in the company. The transaction is part of a grant, award, or other acquisition, as per the transaction code description. The total value of the shares acquired by Weems is approximately $701,477.26.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more